Substance / Medication

Human serum albumin

Overview

Active Ingredient
albumin human, USP
RxNorm CUI
828529

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

7 trials linked to this intervention

7
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
Shrestha Dhan Bahadur, Budhathoki Pravash, Sedhai Yub Raj et al. · Ann Hepatol · 2021
PMID: 34626828Meta-Analysis
A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage.
Zheng Ying-Jun, Zhuo Shi-Jie, Huang Bin et al. · Asian J Surg · 2021
PMID: 34148750Meta-Analysis
A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field.
Naldi M, Giannone F A, Baldassarre M et al. · Eur J Mass Spectrom (Chichester) · 2013
PMID: 24378467RCT
Comparative insights into the effects of thalidomide and lenalidomide on the structure and function of human serum albumin.
Zhang Qiumei, Zhou Yan, Huang Xinyan et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2026
PMID: 41240697Observational
Molecular Interactions of Cobimetinib and Vemurafenib with Human Serum Albumin: a Comparative Biophysical and Computational Analysis.
Cavalieri Gabriele, Marson Domenico, Starz Andrea et al. · Mol Pharm · 2025
PMID: 40662409Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Human serum albumin (substance)
SNOMED CT
387497000
UMLS CUI
C0304925
RxNorm CUI
828529

Clinical Data

This intervention maps to 7 entities in the Ltrl knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
7
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.